Explore CAMELOT‘s latest insights on the topic of blockchain Read more
Latest articles Follow the CAMELOT Management Consultants Magazine!
Go to Flipboard
Press Contact Sandra Gschwendner
+49 89 741185-426   sgsc@camelot-mc.com

Press Releases

24
Apr

CAMELOT distinguished again as “Best Consultancy” in 2018

The quality and agile advice convinced the judges Mannheim, 04/24/2018 – For the fifth time in succession, CAMELOT Management Consultants was honored by the business magazine brand eins and statista, the largest online statistics portal, as the “Best Consultancy” in Germany. This not only testifies to the consistently high quality of CAMELOT’s consulting. The award […]

Read more
09
Apr

Camelot Hypertrust X-Chain provides data security for innovative cancer therapies

CAMELOT Consulting Group introduces new patient-centered blockchain application for pharma and healthcare Mannheim, Montreux, 04/09/2018 – Innovative cell therapies are often the last but most promising form of treatment for cancer patients. However, such procedures are highly complex and involve the exchange of sensitive patient data between many stakeholders. With Hypertrust X-Chain, the CAMELOT Consulting […]

Read more

Stay in touch

Don't miss the latest insights by following us on your favorite channel.

For questions and inquiries, please feel free to contact us.

I agree that my data may be used by CAMELOT Management Consultants AG and associated companies to inform me about service offerings, events, studies, or further activities. The user may revoke his declaration of consent at any time. In this case, please use the following link: https://www.camelot-mc.com/en/privacy-policy/

YesNo

This site uses cookies to provide you with a personalized browsing experience. By using this site you agree to our use of cookies. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close